AAAAAA
Results:
1-19
|
Results: 19
Authors:
COLLEONI M
NOLE F
MINCHELLA I
NOBERASCO C
LUINI A
ORECCHIA A
VERONESI P
ZURRIDA S
VIALE G
GOLDHIRSCH A
Citation: M. Colleoni et al., PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY IN BREAST-CANCER, European journal of cancer, 34(5), 1998, pp. 641-645
Authors:
COLLEONI M
MINCHELLA I
ORVIETO E
PERUZZOTTI G
NOLE F
VIALE G
NOBERASCO C
SACCHINI V
VERONESI P
ORECCHIA R
GOLDHIRSCH A
Citation: M. Colleoni et al., PREDICTION OF RESPONSE TO PRIMARY CHEMOTHERAPY (PCT) FOR OPERABLE BREAST-CANCER, European journal of cancer, 34, 1998, pp. 12-12
Authors:
NOLE F
MUNZONE E
ZAMPINO MG
MINCHELLA I
COLLEONI M
NOBERASCO C
DEPAS T
FAZIO N
DEBRAUD F
PERUZZOTTI G
GOLDHIRSCH A
Citation: F. Nole et al., CONTINUOUS-INFUSION OF 5-FLUOROURACIL (CIFU) GIVEN WITH VINORELBINE (VI) AND CISPLATIN (P) (VIFUP) IN HEAVILY PRETREATED METASTATIC BREAST-CANCER, European journal of cancer, 34, 1998, pp. 33-33
Authors:
NOBERASCO C
PERUZZOTTI G
COLLEONI M
NOLE F
DEBRAUD F
MARTINELLI G
GOLDHIRSCH A
Citation: C. Noberasco et al., HEPATIC TOXICITY DURING ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN BREAST-CANCER, Annals of oncology, 9, 1998, pp. 30-30
Authors:
FERRARI L
BAJETTA E
SEREGNI E
MARTINETTI A
ZILEMBO N
NOBERASCO C
BUZZONI R
BOTTI C
MASSARON S
BICHISAO E
CELIO L
BOMBARDIERI E
Citation: L. Ferrari et al., EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER, International journal of oncology, 11(1), 1997, pp. 163-167
Authors:
MARTINETTI A
BAJETTA E
SEREGNI E
ZILEMBO N
FERRARI L
NOBERASCO C
MASSARON S
RIMASSA L
BOMBARDIERI E
Citation: A. Martinetti et al., SERUM MARKERS OF BONE METASTASES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH FORMESTANE, Tumor biology, 18(4), 1997, pp. 197-205
Authors:
BAJETTA E
ZILEMBO N
NOBERASCO C
MARTINETTI A
MARIANI L
FERRARI L
BUZZONI R
GRECO M
BARTOLI C
SPAGNOLI I
DANESINI GM
ARTALE S
PAOLINI J
Citation: E. Bajetta et al., THE MINIMAL EFFECTIVE EXEMESTANE DOSE FOR ENDOCRINE ACTIVITY IN ADVANCED BREAST-CANCER, European journal of cancer, 33(4), 1997, pp. 587-591
Authors:
BAJETTA E
ZILEMBO N
BARNI S
NOBERASCO C
MARTINETTI A
FERRARI L
SCHIEPATTI G
BUZZONI R
JIRILLO A
AMICHETTI M
DAPRILE M
COMELLA G
BICHISAO E
BOLELLI GF
ATTILI A
BOMBARDIERI E
Citation: E. Bajetta et al., A MULTICENTER, RANDOMIZED, PHARMACOKINETIC, ENDOCRINE AND CLINICAL-STUDY TO EVALUATE FORMESTANE IN BREAST-CANCER PATIENTS AT FIRST RELAPSE - ENDOCRINE AND CLINICAL-RESULTS, Annals of oncology, 8(7), 1997, pp. 649-654
Authors:
ZILEMBO N
BAJETTA E
NOBERASCO C
VICARIO G
BICHISAO E
DAPRILE M
Citation: N. Zilembo et al., HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS, Oncology Reports, 2(4), 1995, pp. 601-602
Authors:
ZILEMBO N
NOBERASCO C
MARTINETTI A
MARIANI L
RIMASSA L
DELVECCHIO M
LAFFRANCHI A
OREFICE S
GALANTE E
SGUOTTI C
BAJETTA E
Citation: N. Zilembo et al., EXEMESTANE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - ADOSE-FINDING STUDY, European journal of cancer, 31A, 1995, pp. 963-963
Authors:
BAJETTA E
ZILEMBO N
NOBERASCO C
Citation: E. Bajetta et al., 2ND-GENERATION AROMATASE INHIBITORS, Tumori, 81(2), 1995, pp. 77-80
Authors:
ZILEMBO N
BAJETTA E
NOBERASCO C
BUZZONI R
VICARIO G
BONO A
LAFFRANCHI A
BIASI G
DOLCI S
BICHISAO E
Citation: N. Zilembo et al., FORMESTANE - AN EFFECTIVE FIRST-LINE ENDOCRINE TREATMENT FOR ADVANCEDBREAST-CANCER, Journal of cancer research and clinical oncology, 121(6), 1995, pp. 378-382
Authors:
NOBERASCO C
BAJETTA E
ZILEMBO N
DILEO A
CAPPUZZO F
BARTOLI C
BONO A
BICHISAO E
Citation: C. Noberasco et al., ACTIVITY OF FORMESTANE IN DE-NOVO TAMOXIFEN-RESISTANT PATIENTS WITH METASTATIC BREAST-CANCER, Oncology, 52(6), 1995, pp. 454-457
Authors:
ZILEMBO N
NOBERASCO C
BAJETTA E
MARTINETTI A
MARIANI L
OREFICE S
BUZZONI R
DIBARTOLOMEO M
DILEO A
LAFFRANCHI A
DISALLE E
Citation: N. Zilembo et al., ENDOCRINOLOGIC AND CLINICAL-EVALUATION OF EXEMESTANE, A NEW STEROIDALAROMATASE INHIBITOR, British Journal of Cancer, 72(4), 1995, pp. 1007-1012
Authors:
BAJETTA E
ZILEMBO N
DILEO A
BUZZONI R
ZAMPINO MG
BIGANZOLI L
NOBERASCO C
Citation: E. Bajetta et al., HORMONE-THERAPY IN ADVANCED BREAST-CARCINOMA - PRESENT AND FUTURE-TRENDS, Cancer treatment reviews, 20(3), 1994, pp. 241-258
Authors:
ZILEMBO N
BUZZONI R
CELIO L
NOBERASCO C
FERRARI L
LAFFRANCHI A
VICARIO G
DOLCI S
BAJETTA E
Citation: N. Zilembo et al., FORMESTANE AS TREATMENT OF ADVANCED BREAST-CANCER IN ELDERLY WOMEN, Tumori, 80(6), 1994, pp. 433-437
Authors:
FERRARI L
ZILEMBO N
BAJETTA E
BUZZONI R
NOBERASCO C
MARTINETTI A
CELIO L
GALANTE E
OREFICE S
CERROTTA AM
Citation: L. Ferrari et al., EFFECT OF 2 4-HYDROXYANDROSTENEDIONE DOSES ON SERUM INSULIN-LIKE GROWTH-FACTOR-I LEVELS IN ADVANCED BREAST-CANCER, Breast cancer research and treatment, 30(2), 1994, pp. 127-132
Authors:
BAJETTA E
ZILEMBO N
BUZZONI R
NOBERASCO C
DILEO A
BARTOLI C
MERSON M
SACCHINI V
MOGLIA D
CELIO L
NELLI P
Citation: E. Bajetta et al., ENDOCRINOLOGIC AND CLINICAL-EVALUATION OF 2 DOSES OF FORMESTANE IN ADVANCED BREAST-CANCER, British Journal of Cancer, 70(1), 1994, pp. 145-150
Authors:
BAJETTA E
ZILEMBO N
BUZZONI R
NOBERASCO C
CELIO L
BICHISAO E
Citation: E. Bajetta et al., EFFICACY AND TOLERABILITY OF 4-HYDROXYANDROSTENEDIONE (4-OHA) AS 1ST-LINE TREATMENT IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER AFTER ADJUVANT THERAPY, Cancer treatment reviews, 19, 1993, pp. 31-36
Risultati:
1-19
|